Antibodies News and Research

RSS

New discovery brings scientists closer to developing an RSV vaccine

Scientists have made an important discovery that could lead to a vaccine that will protect against respiratory syncytial virus (RSV).

9 Oct 2019

Vaccine for deadly RSV could be on the way, scientists say

A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success.

9 Oct 2019

CDC advises vaccination for pregnant women against flu and whooping cough

The Centre for Disease Prevention and Control (CDC) has recommended that all pregnant women should be vaccinated against influenza and whooping cough to provide protection to the baby against these deadly infections during the first few months of their lives. The CDC recommendation released this week Tuesday (8th of October 2019), is that these vaccines against flu and whooping cough are safe for pregnant women and do not affect their unborn babies adversely.

9 Oct 2019

Deficit schizophrenics are physically different from other people

The study, published in Schizophrenia Bulletin on August 19, 2019, points out some differences in mouth structure in people with one form of schizophrenia called deficit schizophrenia, compared with other schizophrenics and non-schizophrenics.

8 Oct 2019

New patterns discovered in the evolution of influenza virus

Skoltech scientists discovered new patterns in the evolution of the influenza virus. This may help predict mutations in the viral genome and ultimately help design better vaccines.

8 Oct 2019

Histone modifications play important role in 'zygotic genome activation'

Scientists at Tokyo Institute of Technology observed changes to the gene-regulating factors during zebrafish development and discovered that modifications to "histone H3", one of the proteins around which DNA is bound, play an important role in "zygotic genome activation" or transition of control of zebrafish embryonic development from maternal material to the zygote .

8 Oct 2019

Scientists show how protein Ikaros orchestrates fine balance to control autoimmunity

The immune system relies on B cells and their ability to make antibodies against an extremely broad range of pathogens. This broad responsiveness bears some risk, as B cells can also turn against healthy tissue - a phenomenon called autoimmunity.

8 Oct 2019

Study identifies genetic marker which could personalize treatment for Crohn's disease

The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn's disease has identified a genetic marker which could individualize drug treatment.

7 Oct 2019

Common genetic variant explains why immunotherapy often fails in Crohn's disease

The reason why a commonly used range of immunotherapy drugs is not effective in some patients with Crohn’s disease has so far not been identified, until now.

7 Oct 2019

GW researchers to study the underlying pathophysiology of myasthenia gravis

The National Institutes of Health awarded a research team at the George Washington University $7.8 million to establish a rare disease network for myasthenia gravis. The network, which will be part of 25 established NIH Rare Diseases Clinical Research Networks, will include basic and clinical investigators, patient advocacy groups, and biotechnology and pharmaceutical companies working together to enhance therapeutic development for this rare disease.

4 Oct 2019

Antibody that targets CXCR6 prevents and reverses multiple sclerosis in mouse model

Multiple sclerosis, an autoimmune disorder, is known to be driven by "helper" T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study from Boston Children's Hospital pinpoints the specific subgroup of helper T cells that cause MS, as well as a protein on their surface, called CXCR6, that marks them.

4 Oct 2019

New NIH grant to support innovative skin testing approach for diagnosing Parkinson's disease

Wenquan Zou, MD, PhD, an expert in degenerative neurological diseases, along with his collaborators Shu G. Chen, PhD also from the Case Western Reserve University School of Medicine, Jiyan Ma, MD, PhD, from Van Andel Institute in Grand Rapids, Michigan, and Thomas Beach, MD, PhD, from Banner Sun Health Research Institute, Sun City, Arizona, have received a five-year, $3.6 million grant from the National Institutes of Health for diagnosing Parkinson's disease (PD) via an innovative skin testing approach.

4 Oct 2019

High-resolution imaging shows how HIV spreads between living cells

In order to treat diseases better, we must understand how they arise.

3 Oct 2019

CAR T-cell therapy may be effective in killing solid tumor cells

There is now a multitude of therapies to treat cancer, from chemotherapy and radiation to immunotherapy and small molecule inhibitors. Chemotherapy is still the most widely used cancer treatment, but chemotherapy attacks all the rapidly dividing cells that it locates within the body, whether they're ultimately harmful or beneficial.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A US study on DNA-based and protein HIV vaccines has shown that an antibody and cellular immune response occurs within six weeks.

2 Oct 2019

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A new study using DNA-based and protein HIV vaccines in various combinations shows that antibody and cellular immune response occurs within 6 weeks from the date of vaccination, and the combination must be administered together for the most rapid protection. This will enable more large-scale testing of the vaccine for effectiveness. About 40 million people today have HIV infections, and 1.2 million deaths a year are related to this infection.

1 Oct 2019

Protozoans protect pathogenic bacteria and enhance their infectious potential

Single celled organisms in the environment are protecting pathogenic bacteria and priming them for human infection, an international team of researchers has discovered.

1 Oct 2019

Penn researchers win NIA grant to study link between Alzheimer's, dementia, and Parkinson's

The Center for Neurodegenerative Disease Research (CNDR) at the University of Pennsylvania has received a grant expected to total $18.1 million to study the underlying genetic mechanisms that cause Alzheimer's Disease, Dementia, and Parkinson's Disease to progress as well as how those mechanisms are related to each other and to the cell-to-cell spread of these disease proteins.

30 Sep 2019

Rice chemist explores how extra amino acid could be used to make life-saving substances

There are 20 amino acids in the standard genetic code. A Rice University professor wants to know what one can do with 21.

27 Sep 2019

Antibodies News and Research

New discovery brings scientists closer to developing an RSV vaccine

Vaccine for deadly RSV could be on the way, scientists say

CDC advises vaccination for pregnant women against flu and whooping cough

Deficit schizophrenics are physically different from other people

New patterns discovered in the evolution of influenza virus

Histone modifications play important role in 'zygotic genome activation'

Scientists show how protein Ikaros orchestrates fine balance to control autoimmunity

Study identifies genetic marker which could personalize treatment for Crohn's disease

Common genetic variant explains why immunotherapy often fails in Crohn's disease

GW researchers to study the underlying pathophysiology of myasthenia gravis

Antibody that targets CXCR6 prevents and reverses multiple sclerosis in mouse model

New NIH grant to support innovative skin testing approach for diagnosing Parkinson's disease

High-resolution imaging shows how HIV spreads between living cells

CAR T-cell therapy may be effective in killing solid tumor cells

New study shows response to HIV vaccine in 6 weeks

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

New study shows response to HIV vaccine in 6 weeks

Protozoans protect pathogenic bacteria and enhance their infectious potential

Penn researchers win NIA grant to study link between Alzheimer's, dementia, and Parkinson's

Rice chemist explores how extra amino acid could be used to make life-saving substances

Antibodies eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News